×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Recent Corporate Integrity Agreements: Impact on Industry-sponsored Publications and Medical Communications Activities
Session Chair(s)
Monica Kwarcinski, PharmD
Vice President, Medical Affairs
Purdue Pharma L.P., United States
Corporate Integrity Agreements: What They Say About Publications, Publication Planning, Transparency and ICMJE
Learning Objective : Describe what policies and procedures the Office of Inspector General (OIG) is requiring companies to have in place on recent Corporate Integrity Agreements (CIA) regarding industry sponsored publications and medical communications activities; Identify the factors to consider when developing, implementing and maintaining standard operating procedures and compliance programs on industry sponsored publication and medical communications activities.
Speaker(s)
Government Enforcement Regarding Medical and Scientific Communications
Kristin Graham Koehler, JD
Sidley Austin LLP, United States
Partner
Corporate Integrity Agreements: What They Say About Publications, Publication Planning, Transparency and ICMJE
Frank J. Rodino, MHS
United States
What Policies and Procedures Medical Communications Department Should Have In Place Based On Recent Corporate Integrity Agreements
Monica Kwarcinski, PharmD
Purdue Pharma L.P., United States
Vice President, Medical Affairs
Have an account?